The Delhi High Court on Monday deferred its hearing on a petition challenging an advisory issued by the Indian Council of Medical Research (ICMR), barring repetition of RT-PCR tests on individuals who tested positive for Covid-19.
The Delhi High Court's directions to National Centre for Disease Control came after it was informed by Amicus Curiae Rajshekhar Rao that there is a need to study the effectiveness of several medications prescribed and administered by the practicing doctor.
The Delhi High Court on Tuesday dismissed a writ petition seeking modification of Covid-19 treatment protocol for mild cases with a cost of Rs 25,000, saying the petition though filed as a Public Interest Litigation is nothing but Publicity Interest Litigation.
While the manufacturer of Covaxin got itself in a jam with Brazil following an inspection of its Hyderabad facility, AstraZeneca’s vaccine was put on hold in several nations after reports of blood clots. How safe are these vaccines?
The Ministry of Health and Family Welfare has introduced a draft National Policy for Rare Diseases 2020 on the direction of the Delhi High Court in response to a plea filed seeking free treatment of rare diseases.
Finding a vaccine suited to India is the least of the problems the government will face. Storing and transporting them at a certain temperature range can be a logistical nightmare, but India is adept at this.